Furthermore, low mouse plasma FAPα levels show inconsistent results with the high expression of FAPα in xenograft tumors tissues, and plasma FAPα levels did not increase along with the tumor growth in our study, which was in line with the result that plasma FAPα had no correlation with the clinicopathological parameters of ESCC patients. This evidence concerns the gene FAP and neoplasm.